StonvexLoading…
StonvexStonvexStonvexCore line items from UNM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.36B | $13.08B | $9.83B | $6.45B |
Operating Income | $302.70M | $933.50M | $715.10M | $660.60M |
Net Income | $232.00M | $738.50M | $564.40M | $524.70M |
EPS (Diluted) | $1.41 | $4.27 | $3.23 | $2.97 |
Total Assets | $62.71B | $63.52B | $63.68B | $62.84B |
Total Liabilities | $51.82B | $52.40B | $52.77B | $51.52B |
Cash & Equivalents | $192.60M | $158.20M | $327.90M | $1.19B |
Free Cash Flow OCF − CapEx | $301.20M | $555.40M | $235.30M | $637.90M |
Shares Outstanding | 164.40M | 172.92M | 174.57M | 176.60M |